Skip to content
healthcare.dev

Droxidopa

NDC 50228-431, droxidopa, capsule, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-431
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-431 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DROXIDOPA300 mg/1

Pharmacologic classes

Catecholamines [CS]; Increased Blood Pressure [PE]

Package NDCNDC-11Package
50228-431-0550228043105500 CAPSULE in 1 BOTTLE (50228-431-05)
50228-431-305022804313030 CAPSULE in 1 BOTTLE (50228-431-30)
50228-431-905022804319090 CAPSULE in 1 BOTTLE (50228-431-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10b02d98-ebb8-4152-bd56-3402417fbf79
  • NADAC price for package 50228043190

    GET /v1/drugs/nadac/50228043190

Use it

Look up 50228-431 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-431 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-431. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.